|
HS Code |
973573 |
| Iupac Name | 1-(4-Bromophenyl)propan-2-one |
| Molecular Formula | C9H9BrO |
| Molar Mass | 213.08 g/mol |
| Cas Number | 27470-14-8 |
| Appearance | Colorless to pale yellow liquid |
| Density | 1.41 g/cm³ |
| Boiling Point | 137 °C at 14 mmHg |
| Solubility In Water | Slightly soluble |
| Refractive Index | 1.5600 |
As an accredited 4-Bromophenylacetone factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A 100g amber glass bottle, tightly sealed with a screw cap, labeled "4-Bromophenylacetone," featuring hazard and handling warnings. |
| Shipping | 4-Bromophenylacetone is shipped in tightly sealed, chemical-resistant containers to prevent leaks and contamination. Packages are clearly labeled with hazard information and comply with local and international transport regulations. Shipping is typically via ground or air freight, handled by certified carriers specializing in chemicals, and includes all necessary safety documentation. |
| Storage | 4-Bromophenylacetone should be stored in a tightly sealed container, protected from light, moisture, and incompatible substances such as strong oxidizers. Keep it in a cool, dry, and well-ventilated area—ideally in a chemical storage cabinet designated for organics. Clearly label the container and restrict access to trained personnel. Avoid exposure to heat or open flames. |
Applications of 4-Bromophenylacetone in Industrial ManufacturingAs a direct manufacturer of 4-Bromophenylacetone, we serve a select group of industrial sectors that rely on its precise performance in specialized synthesis. The following application scenarios reflect established, regulation-driven downstream uses, emphasizing formulation specifics, process integration, recognized compliance frameworks, and representative finished goods produced at industrial scale. 1. Pharmaceutical Intermediate for CNS-Active Drugs4-Bromophenylacetone functions primarily as a critical intermediate in the synthesis of certain central nervous system (CNS)-active pharmaceutical compounds, where its electrophilic brominated acetone moiety participates in key condensation and reductive amination steps. This route supports the precise construction of active pharmaceutical ingredients under cGMP protocols, with process engineers adjusting reagent ratios based on yield optimization and impurity control objectives during multistep batch synthesis. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Fine Chemical Synthesis of Halogenated AromaticsChemical manufacturers incorporate 4-Bromophenylacetone within multi-step syntheses to create halogenated aryl building blocks, enabling access to downstream products through Friedel–Crafts acylation or Grignard coupling. Its unique aromatic halide-alkyl ketone structure complements specialized process chemistry demanding controlled reactivity, particularly during the assembly of value-added intermediates for the agrochemical and specialty polymer industries. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Synthesis of Fragrance Ingredient IntermediatesA select segment of the aroma chemicals industry employs 4-Bromophenylacetone to manufacture halogenated ketone intermediates, which act as key precursors for musk and woody fragrance components. The compound’s specific bromo group and acetyl side chain facilitate subsequent cyclization and reduction reactions, integrating seamlessly into established proprietary processes while ensuring compliance with consumer safety benchmarks for finished fragrances. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Academic and Industrial Research Chemical SourcingResearch institutions and process development units utilize 4-Bromophenylacetone as a model substrate in mechanistic organic studies, kinetic profiling, and catalysis screening. The material's functional group arrangement lends itself to diverse synthetic transformations, supporting the development of novel catalytic protocols, reaction optimization, and proof-of-concept routes for halogenated aryl ketones under documented laboratory controls. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Bromophenylacetone prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Years of direct production have made the significance of precise chemical quality clear to us. Our facility has been synthesizing specialty aromatic ketones for decades, and 4-Bromophenylacetone stands out as one of our flagship products. The demand for aromatic bromides never slackens in fine chemical, pharmaceutical, and material science fields. We put the spotlight here on our experience producing 4-Bromophenylacetone, focusing on its utility, technical features, and the details that separate it from other compounds in daily production.
The molecular signature of 4-Bromophenylacetone is simple, yet striking: C9H9BrO. As an aromatic ketone, it brings together a phenyl ring, a bromine atom at the para position, and an acetone side-chain. Purity measures and reliable analytical profiles matter more to us than grand adjectives, so our batches undergo tight GC and NMR scrutiny before being moved to bottle and drum. Most production runs yield a pale, crystalline solid, typically with a melting range hovering in the low- to mid-90s Celsius.
Chemists visit our plant not looking to be impressed by marketing gloss, but by response curves, clean IR stretches, and sharp, unambiguous HPLC signatures. We've focused on reproducibility and robust handling over convoluted specs.
All steps from bromination to workup and purification get scrutinized for yield, trace impurity content, and impact on downstream applications. Trace water, acidic residues, or those faint halogen byproducts can be disastrous for sensitive applications, so the process isn't just about hitting yield targets. Batch documentation follows every gram through the system, and process operators know exactly why every temperature setpoint and reagent order matters. Conversations with pharmaceutical R&D chemists have taught us to see beyond the COA.
Aromatic bromides often form the backbone for a class of transformations: cross-coupling reactions, selective reductions, or even the formation of complex scaffolds in medicinal chemistry. 4-Bromophenylacetone is no exception. The para-bromine offers a neat handle for Suzuki, Heck, or other palladium-catalyzed couplings. The acetone side chain introduces flexibility for Michael additions, Mannich reactions, or ketone functionalizations.
Researchers and pilot plant teams don't take this versatility for granted. Failures in purity or unexplained chromatogram peaks can destroy weeks of optimization in a synthesis campaign. Direct relationships between our lab floor and our customers’ benches have revealed just how unforgiving downstream transformations can be. That’s why we've set up process feedback cycles: whenever a customer reports a complication, our chemists go back to the bench and run the same reaction, tracking every byproduct.
Trace elements—leftover catalysts or halogenated byproducts—don’t just disappear in post-processing. During early days of manufacturing scale-up, we learned that a single misstep during bromination could introduce persistent impurities. We spent years tweaking bromine quench steps, water washes, and solvent extractions to drop these levels to parts-per-million and below. We run regular impurity profiling using mass spectrometry, zeroing in on fractionally significant peaks.
It’s never enough for a chemical to look "clean" to the eye; a true test comes during a JohnPhos or SPhos-catalyzed cross-coupling or when fed into an enantioselective synthesis. After one major pharmaceutical campaign flagged faint polar impurities, we imposed tighter fraction collection on our distillation and crystallization processes. Today, repeat clients have come to expect the sort of reliability that shaves days off their purification schedules.
In the direct experience of our technical team, 4-Bromophenylacetone stands apart from its methyl, chloro, or unhalogenated variants. Take phenylacetone: it’s widely available and cheaper, yet the absence of a para-bromine alters everything for cross-coupling chemists. Or compare against 4-Chlorophenylacetone: it seems a simple halogen swap on paper, but the reactivity and selectivity profiles shift noticeably in metal-catalyzed work. We’ve supplied both and seen pharmaceutical process teams scrap an entire route because a chlorinated analog failed to couple cleanly or because unwanted elimination appeared during hydrogenation.
Beyond the ketone structure, the bromine atom's electron-withdrawing nature enhances mono-selectivity during substitution. Those subtle effects show up consistently in reaction monitoring. On the other side, some customers want the bromo compound specifically for its predictable behavior in radical reactions—a property the iodo and chloro versions just can’t match. We keep analytical data tracking these side-by-side, and anyone seriously comparing the lot will see that differences aren’t just cosmetic.
Medicinal chemists tell us that 4-Bromophenylacetone often serves as a precursor in the synthesis of CNS-active molecules. The presence of both the bromine anchor and the acetone moiety provide two spots for modular construction. Agrochemical researchers have asked for specialized lots for studies on brominated soil adjuvants or pesticide syntheses.
We also supply research groups delving into polymer chemistry or specialty monomers. In these scenarios, the need for batch-to-batch reproducibility leaps in importance. Nobody wants a pet project derailed by an off-the-shelf lot with hidden stabilizers or minor contaminants that sneak past basic QA checks. We've heard those stories too many times to cut corners.
Dialogue with our end-users has shaped our own understanding. Academic labs want scale flexibility and straightforward documentation. Contract manufacturers care about full documentation trails for regulatory filings. We’ve fielded requests for everything from low-micron powders to pre-dissolved solutions. That cross-talk with users led us to increase spectral data transparency, offer expanded impurity profiles, and even adjust some downstream packaging (certified amber glass isn’t just a packaging gimmick for those who handle light-sensitive intermediates).
As producers, we stay close to our technical roots. We make a habit of pulling random samples for parallel reactions when a new client approaches us, just to check for unanticipated reactivity or hidden process effects. This keeps our claims honest, grounded in real-world lab and plant behavior.
In the real world of chemical manufacturing, safety and sustainability aren’t abstract concepts. Every operator who loads a bromination reactor, every QA technician who handles GC vials—they all notice the effect of small changes in process control. We’ve responded to the specific hazards of brominated intermediates with improved ventilation systems and targeted solvent containment. Fire response drills incorporate actual spill scenarios based on past plant experiences.
Our people have flagged process bottlenecks or occasional temperature excursions before they ever hit external reporting. This iterative, eyes-on-the-process approach leads to fewer out-of-spec lots, but just as importantly, a safer operating environment. A chemical like 4-Bromophenylacetone, despite being less notorious than some of the more reactive halides, requires a steady hand and a full commitment to safe handling protocols. Decades of operation have proven that a cautious step is always quicker than a hurried shortcut.
Each batch ships out with not just a purity certificate but a record of storage recommendations pulled from long-term stability data. Clients who skip dry, cool storage sometimes report degradation after a few months; our own archive samples provide a running log of product stability under typical and exaggerated conditions. Untinted plastic containers, as some experimenters learn the hard way, can lead to unwanted photolysis and color changes in the product.
We’ve responded to these challenges by adjusting labeling, introducing desiccant packs for certain packaging, and running routine shelf-life monitoring. Consultation with our own development labs has even led to process tweaks reducing the formation of colored impurities. We share these results transparently with our partners, so educated choices are possible about shelf life and re-stocking cycles.
No process ever sits still, and neither does the chemistry around 4-Bromophenylacetone. Routine plant walks, regular process audits, and analyst feedback prompt incremental adjustments. Switching from older chlorinated solvents to greener alternatives happened after operators noted persistent skin irritation and process techs flagged solvent losses. Adopting better in-line filtration equipment came about not from a top-down edict but from direct troubleshooting as production scales edged upwards.
Each improvement has stemmed from lived experience rather than consultant checklists. Sometimes, minor tweaks—like altering the order in which solvents get combined, or the way purification washes get sequenced—end up being more valuable than a new reactor vessel. Plant engineers often work alongside senior chemists when integrating these adjustments, and feedback loops operate on tight timelines. Our attitude is practical, not theoretical.
In times of global fluctuation, stable supply lines don’t result from luck. A large part of our reputation hinges on managing raw material reserves, developing local sources of bromine, and staying dialed in to the shipping chain. On multiple occasions, global supply shocks have forced us to change up bromine suppliers on short notice. Each transition triggers new rounds of product qualification, impurity fingerprinting, and close communication with customers likely to notice even trace differences.
Predictable shipping timelines come from direct investment in in-house logistics skill, not third-party convenience. Running our own temperature logging on shipments and providing delivery traceability means customers find out the real time in transit, not a generic "4-6 weeks" estimate. Our backroom team tracks regulatory changes constantly to prevent customs or transit delays from surprising any partner.
As synthetic chemistry grows in complexity, foundational materials carry even greater weight. The trend in pharmaceutical and specialty chemical research points toward sharper demands for trace impurity data, element mapping, and increased transparency around origin and handling. We've accommodated requests for customized documents per client SOP, expanded impurity panels for filing with regulatory entities, and specific lot retention times for sample audits. Our willingness to facilitate process transparency has earned us trust among R&D and QA teams. We listen directly to those shaping the next generation of compounds rather than hiding behind jargon.
One of the regular challenges lies in supporting clients aiming for cGMP campaigns. They bring rigorous batch record demands and fine detail in kinetic profiling. Our investment in direct line process recording, expanded in-process analytics, and more granular solvent and reagent logs wasn’t hypothetical—it grew from years listening to customer needs and our own audit experiences.
Production doesn’t flow without ongoing bumps and lessons. There have been runs where crystallization patterns abruptly shifted, suggesting subtle contaminants or temperature calibration drift. We keep a program of curve monitoring and in-process sampling, and maintain regular dialog with the analytical team to spot and correct these at source. In more persistent cases, we crowdsource problem-solving among team members with decades of hands-on time—often, the origin of a recurring hiccup comes down to a pipe elbow or a gasket swap from a vendor.
Ensuring supply for researchers and commercial partners in different continents means juggling not only logistics hurdles but regulatory overlaps. When a shipment destined for a European plant met an unexpected hold, our documentation and in-house regulatory expertise cut through confusion. Reliable chain of custody, ISO-compliant batch records, and proactive updates allow our product to keep moving.
Purity is the baseline for a specialty aromatic ketone; attention to customer feedback, flexibility, and direct process verification raises the bar. Beyond the chemical identity, we see real differences in structural analogs translating directly to process efficiency or cost savings for our customers. Our accumulated data on batch performance, impurity retention, and client project outcomes informs constant process evolution.
Each kilogram shipped carries layers of real-world testing, process optimization, and honest assessment. We understand that for many users, reliability from the source saves time and trouble at later stages. Our line is driven by chemists who speak the language of the lab and the scale-up plant, willing to share their field experience. 4-Bromophenylacetone isn’t just another SKU; it’s the result of years standing between bench-top insights and commercial-scale solutions.
Every day as manufacturer brings practical challenges—raw material variability, end-user requests for deeper data, and the shifting landscape of both environmental and transport regulation. We step up to these challenges not through polished ad copy but through hands-on diligence and a commitment to integrity that only direct experience brings. That’s the foundation behind every shipment of 4-Bromophenylacetone we produce.